N
2.41
0.04 (1.69%)
| Previous Close | 2.37 |
| Open | 2.51 |
| Volume | 42,839 |
| Avg. Volume (3M) | 44,653 |
| Market Cap | 18,446,238 |
| Price / Earnings (Forward) | 15.43 |
| Price / Sales | 1.54 |
| Price / Book | 4.27 |
| 52 Weeks Range | |
| Earnings Date | 13 May 2025 |
| Profit Margin | -30.70% |
| Operating Margin (TTM) | -27.69% |
| Diluted EPS (TTM) | -0.450 |
| Quarterly Revenue Growth (YOY) | 121.60% |
| Total Debt/Equity (MRQ) | 49.25% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | -3.17 M |
| Levered Free Cash Flow (TTM) | -2.58 M |
| Return on Assets (TTM) | -20.77% |
| Return on Equity (TTM) | -60.08% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | NexGel, Inc | Mixed | Mixed |
AIStockmoo Score
-0.4
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.38 |
|
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 16.15% |
| % Held by Institutions | 8.43% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Aug 2025 | Announcement | NEXGEL Reports Second Quarter 2025 Financial Results |
| 01 Aug 2025 | Announcement | NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement |
| 14 Jul 2025 | Announcement | NEXGEL and STADA AG Announce Expansion of Partnership for North America |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |